Sequoia Financial Advisors LLC Has $424,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Sequoia Financial Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 22.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,205 shares of the financial services provider’s stock after purchasing an additional 597 shares during the period. Sequoia Financial Advisors LLC’s holdings in iShares Biotechnology ETF were worth $424,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Cullen Frost Bankers Inc. boosted its holdings in shares of iShares Biotechnology ETF by 1.5% during the 4th quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock worth $748,000 after buying an additional 82 shares in the last quarter. Transcend Capital Advisors LLC boosted its stake in iShares Biotechnology ETF by 0.8% during the fourth quarter. Transcend Capital Advisors LLC now owns 10,958 shares of the financial services provider’s stock worth $1,449,000 after acquiring an additional 92 shares in the last quarter. Chicago Partners Investment Group LLC boosted its stake in iShares Biotechnology ETF by 2.5% during the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock worth $510,000 after acquiring an additional 94 shares in the last quarter. WealthCare Investment Partners LLC increased its stake in iShares Biotechnology ETF by 0.9% in the fourth quarter. WealthCare Investment Partners LLC now owns 10,348 shares of the financial services provider’s stock valued at $1,375,000 after purchasing an additional 96 shares in the last quarter. Finally, Capital Investment Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after purchasing an additional 99 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.5 %

Shares of NASDAQ:IBB opened at $134.09 on Wednesday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The stock’s 50 day moving average is $136.26 and its 200-day moving average is $139.57. The firm has a market capitalization of $6.11 billion, a price-to-earnings ratio of 27.83 and a beta of 0.77.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th will be paid a $0.1212 dividend. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date is Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.